Phase II Study of Epacadostat (INCB024360) With Pembrolizumab (MK3475) in Metastatic or Unresectable Gastroesophageal Junction and Gastric Adenocarcinoma Requiring Paired Biopsies
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Epacadostat (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 18 Jan 2018 Trial design of the study presented at the 2018 Gastrointestinal Cancers Symposium.
- 19 Sep 2017 Planned End Date changed from 1 Jun 2019 to 1 Sep 2019.
- 19 Sep 2017 Planned primary completion date changed from 1 Jun 2019 to 1 Sep 2019.